From October 1, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 10,342,722 shares, representing 6.76% for $309.28 million under the buyback announced on May 2, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.38 USD | -4.62% | +0.87% | -22.70% |
06-13 | The Chemours Company Appoints Livingston Tony Satterthwaite to Its Board of Directors | CI |
06-07 | Mizuho Initiates Chemours With Neutral Rating, $25 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.70% | 3.81B | |
+3.85% | 79B | |
+3.55% | 33.48B | |
+14.54% | 18.74B | |
+10.79% | 12.06B | |
-6.29% | 10.43B | |
-21.89% | 10.17B | |
-2.89% | 8.87B | |
-3.12% | 8.51B | |
-5.64% | 7.26B |
- Stock Market
- Equities
- CC Stock
- News The Chemours Company
- Tranche Update on The Chemours Company (NYSE: CC)'s Equity Buyback Plan announced on May 2, 2022.